- Report
- January 2022
- 42 Pages
Global
From €3316EUR$3,750USD£2,863GBP
- Report
- September 2021
- 144 Pages
China
From €3537EUR$4,000USD£3,054GBP
- Report
- June 2021
- 197 Pages
Latin America
From €3537EUR$4,000USD£3,054GBP
- Report
- October 2023
- 253 Pages
Global
From €4378EUR$4,950USD£3,780GBP
- Report
- August 2024
- 136 Pages
Global
From €2652EUR$2,999USD£2,290GBP
- Report
- July 2024
- 150 Pages
Global
From €3316EUR$3,750USD£2,863GBP
- Report
- January 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- May 2024
- 100 Pages
Africa
From €884EUR$1,000USD£764GBP
€1769EUR$2,000USD£1,527GBP
- Report
- April 2024
- 80 Pages
China
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
France
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
Germany
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
India
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
South Korea
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- April 2024
- 80 Pages
United States
From €663EUR$750USD£573GBP
€1327EUR$1,500USD£1,145GBP
- Report
- October 2023
- 150 Pages
Global
From €3405EUR$3,850USD£2,940GBP
€4289EUR$4,850USD£3,703GBP
- Report
- June 2023
- 115 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- July 2024
- 158 Pages
Global
From €3759EUR$4,250USD£3,245GBP

The NAT Screening market within the context of In Vitro Diagnostics is a segment of the healthcare industry that focuses on the development and commercialization of tests that detect the presence of infectious agents in a sample. These tests are used to diagnose and monitor the spread of infectious diseases, such as HIV, hepatitis, and other viruses. NAT Screening tests are used in a variety of settings, including clinical laboratories, hospitals, and public health departments.
NAT Screening tests are typically performed using a variety of technologies, such as polymerase chain reaction (PCR), nucleic acid hybridization, and enzyme-linked immunosorbent assays (ELISA). These tests are used to detect the presence of specific genetic material in a sample, which can be used to identify the presence of a particular infectious agent.
Some companies in the NAT Screening market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more